109 related articles for article (PubMed ID: 31190675)
1. The impact of efflux pumps on meropenem susceptibility among metallo-β-lactamase-producing and nonproducing Pseudomonas aeruginosa: Insights for better antimicrobial stewardship.
Perez LRR
Infect Control Hosp Epidemiol; 2019 Aug; 40(8):957-958. PubMed ID: 31190675
[No Abstract] [Full Text] [Related]
2. Antimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution.
Stultz JS; Arnold SR; Shelton CM; Bagga B; Lee KR
Am J Infect Control; 2019 Dec; 47(12):1513-1515. PubMed ID: 31253550
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
Hakki M; Humphries RM; Hemarajata P; Tallman GB; Shields RK; Mettus RT; Doi Y; Lewis JS
Clin Infect Dis; 2019 May; 68(12):2045-2052. PubMed ID: 30256922
[TBL] [Abstract][Full Text] [Related]
4. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
5. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
[TBL] [Abstract][Full Text] [Related]
6. Metallo-β-lactamase-production in meropenem-susceptible Pseudomonas aeruginosa isolates: risk for silent spread.
Picão RC; Carrara-Marroni FE; Gales AC; Venâncio EJ; Xavier DE; Tognim MC; Pelayo JS
Mem Inst Oswaldo Cruz; 2012 Sep; 107(6):747-51. PubMed ID: 22990963
[TBL] [Abstract][Full Text] [Related]
7. Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital.
Munting A; Damas J; Viala B; Prod'hom G; Guery B; Senn L
Antimicrob Resist Infect Control; 2022 Dec; 11(1):165. PubMed ID: 36585736
[TBL] [Abstract][Full Text] [Related]
8. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
[TBL] [Abstract][Full Text] [Related]
9. Forecasting from phenotypic testing to an antimicrobial stewardship strategy: Does the time to positivity of a blue-carba test predict the meropenem susceptibility level among carbapenemase producers?
Perez LRR
Infect Control Hosp Epidemiol; 2019 Aug; 40(8):958-960. PubMed ID: 31196234
[No Abstract] [Full Text] [Related]
10. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
[TBL] [Abstract][Full Text] [Related]
12. Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012-2017 surveillance data.
Abbara S; Domenech de Cellès M; Batista R; Mira JP; Poyart C; Poupet H; Casetta A; Kernéis S
J Hosp Infect; 2020 Feb; 104(2):150-157. PubMed ID: 31605739
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
[TBL] [Abstract][Full Text] [Related]
15. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
[TBL] [Abstract][Full Text] [Related]
16. Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.
Sabet M; Tarazi Z; Griffith DC
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323049
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
18. Metallo-β-lactamase-producing Pseudomonas aeruginosa in two Iranian teaching hospitals, their antimicrobial susceptibility and serotypes.
Yousefi S; Nahaei MR; Farajnia S; Akhi MT; Ghotaslou R; Lotfipour F; Soroush MH
J Chemother; 2011 Apr; 23(2):114-6. PubMed ID: 21571630
[No Abstract] [Full Text] [Related]
19. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
20. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
